New drugs for treatment of gastric cancer

This publication has 29 references indexed in Scilit:

• UFT and leucovorin in first-line chemotherapy for patients with metastatic gastric cancer. An Early Clinical Studies Group (ECSG)/European Organization for Research Treatment of Cancer (EORTC) phase II trial
  European Journal Of Cancer, 2001
• Phase II Study of S-1, a Novel Oral Derivative of 5-Fluorouracil, in Advanced Gastric Cancer
  Oncology, 2000
• An Early Phase II Study of Oral S-1, a Newly Developed 5-Fluorouracil Derivative for Advanced and Recurrent Gastrointestinal Cancers
  Oncology, 1999
• Raltitrexed (Tomudex™) in combination with platinum-based agents and/or anthracyclines: preliminary results of phase I clinical trials
  European Journal Of Cancer, 1999
• Recent developments in oral chemotherapy options for gastric carcinoma.
  Drugs, 1999
• Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1M tegafur–0.4M gimestat–1M otastat potassium) in advanced gastric cancer patients
  European Journal Of Cancer, 1998
• Combination chemotherapy of oral 5'-deoxy-5-fluorouridine and cisplatin in advanced gastric cancer: a phase II study
  Journal of Korean Medical Science, 1998
• Treatment of patients with advanced gastric carcinoma with the combination of etoposide plus oral tegafur modulated by uracil and leucovorin: A phase II study of the ONCOPAZ Cooperative Group
  Cancer, 1996
• Phase II Trial of Oral UFT and Leucovorin in Advanced Gastric Carcinoma
  American Journal of Clinical Oncology, 1996
• A Cooperative Randomized Study on Tegafur plus Mitomycin C versus Combined Tegafur and Uracil plus Mitomycin C in the Treatment of Advanced Gastric Cancer
  Japanese Journal of Cancer Research, 1991